Progesterone Receptors and Seizure Susceptibility
黄体酮受体和癫痫易感性
基本信息
- 批准号:7671859
- 负责人:
- 金额:$ 30.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAllopregnanoloneAnabolismAnimal ModelAnticonvulsantsAntisense OligonucleotidesBindingBiological ModelsBrain regionChemosensitizationConditionDNADataDevelopmentDiseaseElectrophysiology (science)ElevationEndocrineEpilepsyEpileptogenesisEquilibriumEventExhibitsFinasterideFunctional disorderGABA ReceptorGene ExpressionGene TargetingGenesGenetic ModelsGenomicsGoalsHippocampus (Brain)HormonesInterventionKindling (Neurology)Knock-outKnockout MiceLeadLinkMediatingMenarcheMenopauseMessenger RNAMethodologyModelingMolecularMolecular GeneticsMolecular Mechanisms of ActionMusNeuronsNuclearOutcomeOxidoreductasePathway interactionsPhysiologicalPlayPolymerase Chain ReactionPredispositionPregnancyPrincipal InvestigatorProgesteroneProgesterone ReceptorsPropertyProteinsRU-486RateReceptor InhibitionRegulationResearch PersonnelResistanceReverse Transcriptase Polymerase Chain ReactionRoleSeizuresStudy SectionTechniquesTestingTimeTransgenic OrganismsUnited StatesWestern BlottingWild Type MouseWithdrawalWomandentate gyrusgranule cellimprovedinnovationknock-downmouse modelnon-genomicnovelpatch clampperimenstrualpostsynapticprogramspromoterprotein expressionreceptorreceptor bindingreceptor expressionreceptor functionrelating to nervous systemresearch studyresponsetranscription factortransmission process
项目摘要
DESCRIPTION (provided by applicant): Progesterone (P) plays a key role in the pathophysiology of "catamenial epilepsy", a menstrual cyclerelated seizure disorder that affects many women with epilepsy. While P's endocrine actions are mediated by the progesterone receptor (PR), P's molecular mechanism of action in seizure activity is not clearly understood. P modulates seizure activity partly through conversion to allopregnanolone, which enhances GABAA receptor function. Recently, we have made the novel discovery that PRs play a key role in seizure susceptibility. Our preliminary results underscore that PR knockout (PRKO) mice exhibit elevated seizure threshold and resistance to kindling epileptogenesis, suggesting that PRs mediate seizure susceptibility. In this application, we propose to elucidate the molecular mechanisms whereby PRs increase seizure susceptibility in the hippocampus, utilizing genetic, molecular and electrophysiological approaches. We hypothesize that progesterone's actions on seizure activity are due in part to PR regulation of hippocampal GABA^ receptor subunit expression and function that results in reduced inhibition and thereby seizure susceptibility. PR-mediated "subunit switching" leading to alterations of GABAA receptor subunit composition and functional properties are the molecular mechanism by which P controls seizure susceptibility. We propose to test this hypothesis critically utilizing 3 model systems that are well established in our lab: 1) PRKO transgenic mouse model; 2) Antisense PR inhibition in wild-type mice; and 3) RU-486 blockade of PR function in wild-type mice. The Specific Aims of this proposal are: 1) to determine whether PRs increase seizure susceptibility using the kindling model of epilepsy; and 2) to determine whether PRs are involved in P induced alterations in GABAA receptor subunit expression and channel function. Aim 1 will examine the rate of hippocampus kindling in WT and PRKO mice, with and without P and/or finasteride treatment, as an indicator of epileptogenesis. Aim 2 will assess mRNA (real-time PCR) and protein levels (Westerns blots) of GABAA receptor subunits in hippocampal subfields in WT and PRKO mice treated with P, P+finasteride, and 24 hrs after neurosteroid withdrawal. We will verify the functional importance of P induced changes in GABAA receptor subunit expression by recording GABA-gated CI" currents in acutely isolated hippocampal neurons using patch-clamp electrophysiology. Significance. The proposed study will provide novel information on the P mechanisms governing regulation of seizure susceptibility, which could lead to improved understanding of catamenial epilepsy. Relevance. Women with catamenial epilepsy have seizures clustered around their monthly cycle. However, currently the pathophysiology of this condition is not fully understood. The studies proposed in this application will help better understand the disease mechanism and thereby allow development of specific therapies for catamenial epilepsy and other conditions associated with fluctuations in progesterone levels.
描述(由申请人提供):黄体酮 (P) 在“经期癫痫”的病理生理学中发挥着关键作用,“经期癫痫”是一种与月经周期相关的癫痫疾病,影响许多患有癫痫的女性。虽然 P 的内分泌作用是由孕激素受体 (PR) 介导的,但 P 在癫痫发作活动中的分子作用机制尚不清楚。 P 部分通过转化为四氢孕酮来调节癫痫发作活动,从而增强 GABAA 受体功能。最近,我们有了新的发现,即 PR 在癫痫易感性中起着关键作用。我们的初步结果强调,PR 敲除 (PRKO) 小鼠表现出较高的癫痫阈值和对引发癫痫发生的抵抗力,表明 PR 介导癫痫易感性。在此应用中,我们建议利用遗传、分子和电生理学方法阐明 PR 增加海马癫痫易感性的分子机制。我们假设黄体酮对癫痫发作活动的作用部分是由于PR对海马GABA 受体亚基表达和功能的调节,导致抑制减少,从而癫痫易感性降低。 PR 介导的“亚基转换”导致 GABAA 受体亚基组成和功能特性的改变,是 P 控制癫痫易感性的分子机制。我们建议利用我们实验室成熟的 3 个模型系统来批判性地检验这一假设:1)PRKO 转基因小鼠模型; 2) 野生型小鼠中的反义PR抑制; 3) RU-486 阻断野生型小鼠的 PR 功能。该提案的具体目标是: 1) 使用癫痫点燃模型确定 PR 是否会增加癫痫发作的易感性; 2) 确定 PR 是否参与 P 诱导的 GABAA 受体亚基表达和通道功能的改变。目标 1 将检查 WT 和 PRKO 小鼠中海马点燃率,无论是否接受 P 和/或非那雄胺治疗,作为癫痫发生的指标。目标 2 将评估接受 P、P+非那雄胺治疗以及神经类固醇停药后 24 小时的 WT 和 PRKO 小鼠海马亚区 GABAA 受体亚基的 mRNA(实时 PCR)和蛋白质水平(蛋白质印迹)。我们将通过使用膜片钳电生理学记录急性分离的海马神经元中的 GABA 门控 CI 电流,验证 P 诱导 GABAA 受体亚基表达变化的功能重要性。意义。本研究将为控制 GABAA 受体亚基表达的 P 机制提供新的信息。癫痫易感性,这可能会提高对经期癫痫的了解。然而,目前,经期癫痫的病理生理学仍集中在女性的月经周期上。本申请中提出的研究将有助于更好地了解这种疾病的机制,从而开发针对月经期癫痫和与孕酮水平波动相关的其他疾病的特定疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Doodipala Samba Reddy其他文献
Doodipala Samba Reddy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Doodipala Samba Reddy', 18)}}的其他基金
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10004277 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10475298 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10013749 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10693904 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10266034 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10475109 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10248384 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
相似国自然基金
TiC-TiB2颗粒喷射成形原位合成及其对M2高速工具钢共晶碳化物形成与演化的影响
- 批准号:52361020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
植被群落演替对河道水流结构和纵向离散特性影响机制研究
- 批准号:52309088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带印度洋海表皮温日变化的数值模拟及对海气热通量的影响
- 批准号:42376002
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
协同遥感和气候模型的城市高温热浪时空特征及其对热暴露影响研究
- 批准号:42371397
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
O-GlcNac Modulation of GABAergic Transmission
O-GlcNac 对 GABA 能传输的调节
- 批准号:
10754746 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Adolescent alcohol exposure: impact on neuronal activation, steroids, and metabolomic profiles
青少年酒精暴露:对神经元激活、类固醇和代谢组学特征的影响
- 批准号:
10629731 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
Allopregnanolone 的新型鼻内制剂,一种阿尔茨海默病的再生疗法
- 批准号:
10698555 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
An RDoC Approach to Perinatal Affective Disorders: The Role of Neuroactive Steroids and Potential Threat
RDoC 治疗围产期情感障碍的方法:神经活性类固醇的作用和潜在威胁
- 批准号:
10595551 - 财政年份:2022
- 资助金额:
$ 30.88万 - 项目类别:
Exploring the role of neuroactive steroids in Tourette syndrome
探索神经活性类固醇在抽动秽语综合征中的作用
- 批准号:
10656348 - 财政年份:2022
- 资助金额:
$ 30.88万 - 项目类别: